Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11294654rdf:typepubmed:Citationlld:pubmed
pubmed-article:11294654lifeskim:mentionsumls-concept:C0018557lld:lifeskim
pubmed-article:11294654lifeskim:mentionsumls-concept:C0245382lld:lifeskim
pubmed-article:11294654lifeskim:mentionsumls-concept:C0175631lld:lifeskim
pubmed-article:11294654lifeskim:mentionsumls-concept:C1704675lld:lifeskim
pubmed-article:11294654lifeskim:mentionsumls-concept:C1514562lld:lifeskim
pubmed-article:11294654lifeskim:mentionsumls-concept:C1883221lld:lifeskim
pubmed-article:11294654lifeskim:mentionsumls-concept:C2827662lld:lifeskim
pubmed-article:11294654lifeskim:mentionsumls-concept:C1704241lld:lifeskim
pubmed-article:11294654lifeskim:mentionsumls-concept:C0205288lld:lifeskim
pubmed-article:11294654lifeskim:mentionsumls-concept:C0024485lld:lifeskim
pubmed-article:11294654lifeskim:mentionsumls-concept:C0013852lld:lifeskim
pubmed-article:11294654lifeskim:mentionsumls-concept:C0037633lld:lifeskim
pubmed-article:11294654lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:11294654lifeskim:mentionsumls-concept:C1382100lld:lifeskim
pubmed-article:11294654lifeskim:mentionsumls-concept:C1883204lld:lifeskim
pubmed-article:11294654lifeskim:mentionsumls-concept:C0332120lld:lifeskim
pubmed-article:11294654lifeskim:mentionsumls-concept:C1880389lld:lifeskim
pubmed-article:11294654lifeskim:mentionsumls-concept:C1707271lld:lifeskim
pubmed-article:11294654pubmed:issue15lld:pubmed
pubmed-article:11294654pubmed:dateCreated2001-4-11lld:pubmed
pubmed-article:11294654pubmed:abstractTextGalectin-3, a beta-galactoside binding protein, contains a C-terminal carbohydrate recognition domain (CRD) and an N-terminal domain that includes several repeats of a proline-tyrosine-glycine-rich motif. Earlier work based on a crystal structure of human galectin-3 CRD, and modeling and mutagenesis studies of the closely homologous hamster galectin-3, suggested that N-terminal tail residues immediately preceding the CRD might interfere with the canonical subunit interaction site of dimeric galectin-1 and -2, explaining the monomeric status of galectin-3 in solution. Here we describe high-resolution NMR studies of hamster galectin-3 (residues 1--245) and several of its fragments. The results indicate that the recombinant N-terminal fragment Delta 126--245 (residues 1--125) is an unfolded, extended structure. However, in the intact galectin-3 and fragment Delta 1--93 (residues 94--245), N-terminal domain residues lying between positions 94 and 113 have significantly reduced mobility values compared with those expected for bulk N-terminal tail residues, consistent with an interaction of this segment with the CRD domain. In contrast to the monomeric status of galectin-3 (and fragment Delta 1--93) in solution, electron microscopy of negatively stained and rotary shadowed samples of hamster galectin-3 as well as the CRD fragment Delta 1--103 (residues 104--245) show the presence of a significant proportion (up to 30%) of oligomers. Similar imaging of the N-terminal tail fragment Delta 126--245 reveals the presence of fibrils formed by intermolecular interactions between extended polypeptide subunits. Oligomerization of substratum-adsorbed galectin-3, through N- and C-terminal domain interactions, could be relevant to the positive cooperativity observed in binding of the lectin to immobilized multiglycosylated proteins such as laminin.lld:pubmed
pubmed-article:11294654pubmed:languageenglld:pubmed
pubmed-article:11294654pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11294654pubmed:citationSubsetIMlld:pubmed
pubmed-article:11294654pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11294654pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11294654pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11294654pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11294654pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11294654pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11294654pubmed:statusMEDLINElld:pubmed
pubmed-article:11294654pubmed:monthAprlld:pubmed
pubmed-article:11294654pubmed:issn0006-2960lld:pubmed
pubmed-article:11294654pubmed:authorpubmed-author:FeeneyJJlld:pubmed
pubmed-article:11294654pubmed:authorpubmed-author:BirdsallBBlld:pubmed
pubmed-article:11294654pubmed:authorpubmed-author:HughesR CRClld:pubmed
pubmed-article:11294654pubmed:authorpubmed-author:BurdettI DIDlld:pubmed
pubmed-article:11294654pubmed:authorpubmed-author:BawumiaSSlld:pubmed
pubmed-article:11294654pubmed:authorpubmed-author:BarboniE AEAlld:pubmed
pubmed-article:11294654pubmed:issnTypePrintlld:pubmed
pubmed-article:11294654pubmed:day17lld:pubmed
pubmed-article:11294654pubmed:volume40lld:pubmed
pubmed-article:11294654pubmed:ownerNLMlld:pubmed
pubmed-article:11294654pubmed:authorsCompleteYlld:pubmed
pubmed-article:11294654pubmed:pagination4859-66lld:pubmed
pubmed-article:11294654pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11294654pubmed:meshHeadingpubmed-meshheading:11294654...lld:pubmed
pubmed-article:11294654pubmed:meshHeadingpubmed-meshheading:11294654...lld:pubmed
pubmed-article:11294654pubmed:meshHeadingpubmed-meshheading:11294654...lld:pubmed
pubmed-article:11294654pubmed:meshHeadingpubmed-meshheading:11294654...lld:pubmed
pubmed-article:11294654pubmed:meshHeadingpubmed-meshheading:11294654...lld:pubmed
pubmed-article:11294654pubmed:meshHeadingpubmed-meshheading:11294654...lld:pubmed
pubmed-article:11294654pubmed:meshHeadingpubmed-meshheading:11294654...lld:pubmed
pubmed-article:11294654pubmed:meshHeadingpubmed-meshheading:11294654...lld:pubmed
pubmed-article:11294654pubmed:meshHeadingpubmed-meshheading:11294654...lld:pubmed
pubmed-article:11294654pubmed:meshHeadingpubmed-meshheading:11294654...lld:pubmed
pubmed-article:11294654pubmed:meshHeadingpubmed-meshheading:11294654...lld:pubmed
pubmed-article:11294654pubmed:meshHeadingpubmed-meshheading:11294654...lld:pubmed
pubmed-article:11294654pubmed:meshHeadingpubmed-meshheading:11294654...lld:pubmed
pubmed-article:11294654pubmed:meshHeadingpubmed-meshheading:11294654...lld:pubmed
pubmed-article:11294654pubmed:meshHeadingpubmed-meshheading:11294654...lld:pubmed
pubmed-article:11294654pubmed:meshHeadingpubmed-meshheading:11294654...lld:pubmed
pubmed-article:11294654pubmed:year2001lld:pubmed
pubmed-article:11294654pubmed:articleTitleNMR solution studies of hamster galectin-3 and electron microscopic visualization of surface-adsorbed complexes: evidence for interactions between the N- and C-terminal domains.lld:pubmed
pubmed-article:11294654pubmed:affiliationMolecular Structure Division, National Institute for Medical Research, Mill Hill, London, NW7 1AA, UK.lld:pubmed
pubmed-article:11294654pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11294654pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11294654lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11294654lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11294654lld:pubmed